首页/数据集/Number and percentage of patients under MS specific DMDs at baseline.

Number and percentage of patients under MS specific DMDs at baseline.

NIAID Data Ecosystem2026-03-09 收录

数据链接：

https://figshare.com/articles/dataset/Number_and_percentage_of_patients_under_MS_specific_DMDs_at_baseline_/3149878 数据链接链接失效反馈

官方服务：

资源简介：

Number and percentage of patients under MS specific DMDs at baseline.

应用场景：

创建时间：

2016-04-04

多发性硬化症治疗

药物动力学评估

The primary objective of this study is to evaluate the effect of BG00012 (dimethyl fumarate) on brain magnetic resonance imaging (MRI) lesions in pediatric participants with relapsing-remitting multip

NIAID Data Ecosystem40

DMT utilization at Federico II and Vanvitelli MS centres.

多发性硬化症治疗

疾病修饰治疗用药分析

DMT utilization at Federico II and Vanvitelli MS centres.

Figshare2019-09-19 更新30

Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3‑Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)

药物设计

多发性硬化症治疗

The lipid kinase phosphoinositide 3-kinase γ (PI3Kγ) has attracted attention as a potential target to treat a variety of autoimmune disorders, including multiple sclerosis, due to its role in immune m

NIAID Data Ecosystem30

Table S1 - Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

多发性硬化症治疗

药物疗效比较

Assignation to treatment dosage by treating centres. The table shows number of patients assigned to either Rebif dosage at each of the participating centres. Odds relative to the reference centre (IT-

Figshare2015-12-02 更新30

DMTs used by the patients with RRMS from the 2016 and 2019 cohorts.

多发性硬化症治疗

疾病修正治疗药物

DMTs used by the patients with RRMS from the 2016 and 2019 cohorts.

Figshare2022-04-29 更新30